Tumor markers revealed mild elevations of carcinoembryonic antigen (CEA) 6.5 ng/mL (reference range: 0.0-4.7) and cancer antigen 19-9 (CA 19-9) 40 U/mL (reference range: 0-35). This evidence concerns the gene CEACAM5 and neoplasm.